STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2683 by analyst upside · 2026-06-27
PDEX
Pro-Dex, Inc.
Healthcare · Market Cap $196M · P/E 18.2x
ANALYST PRICE TARGET
+13.9%
implied upside to consensus target
Current Price $61.47
Consensus Target $70.0
Bull Target $70.0
Bear Target $70.0
Analysts Covering 1
ANALYST CONSENSUS — BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $23.47
52-Week High $68.99
YTD Return +63.0%
FUNDAMENTALS
Market Cap $196M
P/E Ratio (TTM) 18.2x
Forward P/E 29.8x
EPS (TTM) $3.37
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $75M
Profit Margin 16.1%
52-WEEK RANGE
52-Week Low $23.47
52-Week High $68.99
Current Price $61.47
Bear Target $70.0
Bull Target $70.0
● Now $61.47 ● Target $70.0
TRADING DATA
Avg Volume 43K
YTD Return +63.0%
Analyst Count 1
Consensus Buy
Upside to Target +13.9%
Last Updated 2026-06-27

ANALYST SUMMARY

Pro-Dex, Inc. (PDEX) is currently trading at $61.47 with a Wall Street consensus price target of $70.0, implying potential upside of 13.9% over the next 12 months. 1 analysts currently cover PDEX, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $70.0, while the most cautious has a target of $70.0.

PDEX operates in the Healthcare sector with a market capitalisation of $196M. The stock is up 63.0% year-to-date and is currently trading near the upper end of its 52-week range of $23.47 – $68.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PDEX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Ascendiant Capital — Reiterated
Buy → Buy 2026-05-12 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-05-27 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-02-22 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2024-11-11 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2024-09-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →